Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)
CUSIP: 747324101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 62,130,557
- Total 13F shares
- 28,117,599
- Share change
- +5,151,648
- Total reported value
- $93,075,160
- Put/Call ratio
- 3.8%
- Price per share
- $3.31
- Number of holders
- 78
- Value change
- +$16,220,879
- Number of buys
- 43
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 747324101?
CUSIP 747324101 identifies PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 747324101:
Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PFIZER INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
7,032,770
|
$19,410,445 | — | 17 Mar 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
6.7%
|
4,184,100
|
$17,824,266 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
6.2%
|
3,861,179
|
$16,448,623 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
4.2%
|
2,594,324
|
$11,051,820 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
2.9%
|
1,794,195
|
$7,643,271 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
2.7%
|
1,662,408
|
$7,081,858 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,401,425
|
$5,970,070 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,477,975
|
$4,869,165 | — | 26 Apr 2022 | |
| Bayer World Investments B.V. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
2,742,338
|
$3,839,273 | — | 13 Oct 2021 | |
| Aberdeen Group plc |
13F
|
Company |
1.1%
|
708,303
|
$3,017,371 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.94%
|
583,009
|
$2,483,618 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.79%
|
493,759
|
$2,103,414 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
492,462
|
$2,097,888 | — | 31 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.71%
|
442,500
|
$1,885,050 | — | 31 Mar 2024 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.62%
|
382,606
|
$1,629,902 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
1,118,854
|
$1,566,396 | — | 13 Oct 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
340,121
|
$1,449,252 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
336,691
|
$1,434,304 | — | 31 Mar 2024 | |
| Decheng Capital LLC |
13F
|
Company |
0.53%
|
326,810
|
$1,392,211 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.52%
|
321,665
|
$1,370,294 | — | 31 Mar 2024 | |
| Jay Feingold |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
747,862
mixed-class rows
|
$1,089,573 | — | 24 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
231,495
|
$986,169 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.28%
|
175,252
|
$746,573 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.27%
|
165,000
|
$702,900 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
162,108
|
$690,580 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.25%
|
153,006
|
$651,806 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.24%
|
148,000
|
$630,000 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.24%
|
147,180
|
$626,987 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.22%
|
139,142
|
$592,000 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.21%
|
133,576
|
$569,033 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
109,355
|
$465,852 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.16%
|
101,810
|
$433,711 | — | 31 Mar 2024 | |
| Ken Kobayashi |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
110,878
|
$424,663 | — | 29 Dec 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.14%
|
89,471
|
$381,000 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.13%
|
82,447
|
$351,224 | — | 31 Mar 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.12%
|
74,903
|
$319,087 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
69,451
|
$295,861 | — | 31 Mar 2024 | |
| Fan Yu |
13F
|
Individual |
0.11%
|
69,303
|
$295,231 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.11%
|
68,358
|
$291,205 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.11%
|
65,862
|
$280,572 | — | 31 Mar 2024 | |
| Cable Car Capital, LP |
13F
|
Company |
0.1%
|
61,606
|
$262,442 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
61,234
|
$260,857 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.09%
|
57,000
|
$242,820 | — | 31 Mar 2024 | |
| Ronald Herbst |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
118,674
mixed-class rows
|
$234,796 | — | 07 Oct 2021 | |
| PIER 88 INVESTMENT PARTNERS LLC |
13F
|
Company |
0.08%
|
51,360
|
$218,794 | — | 31 Mar 2024 | |
| UNIVERSITY OF CHICAGO |
13F
|
Company |
0.08%
|
48,731
|
$207,594 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
44,695
|
$190,401 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
43,527
|
$185,425 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.07%
|
40,452
|
$172,326 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
37,351
|
$159,115 | — | 31 Mar 2024 |
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q2 2024
As of 30 Jun 2024,
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,117,599 shares.
The largest 10 holders included
Deep Track Capital, LP, Laurion Capital Management LP, BlackRock Inc., Balyasny Asset Management L.P., VANGUARD GROUP INC, Ikarian Capital, LLC, MILLENNIUM MANAGEMENT LLC, STEMPOINT CAPITAL LP, Blue Owl Capital Holdings LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
69
Q2 2024 holders
78
Holder diff
9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.